126 related articles for article (PubMed ID: 38934231)
21. Calcium hydroxylapatite filler: an overview of safety and tolerability.
Pavicic T
J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
[TBL] [Abstract][Full Text] [Related]
22. Calcium Hydroxylapatite Dermal Filler for Treatment of Dorsal Hand Volume Loss: Results From a 12-Month, Multicenter, Randomized, Blinded Trial.
Goldman MP; Moradi A; Gold MH; Friedmann DP; Alizadeh K; Adelglass JM; Katz BE
Dermatol Surg; 2018 Jan; 44(1):75-83. PubMed ID: 28562435
[TBL] [Abstract][Full Text] [Related]
23. Combining topical dermal infused exosomes with injected calcium hydroxylapatite for enhanced tissue biostimulation.
Chernoff G
J Cosmet Dermatol; 2023 Mar; 22 Suppl 1():15-27. PubMed ID: 36988469
[TBL] [Abstract][Full Text] [Related]
24. Calcium Hydroxylapatite With Integral Lidocaine Provides Improved Pain Control for the Correction of Nasolabial Folds.
Schachter D; Bertucci V; Solish N
J Drugs Dermatol; 2016 Aug; 15(8):1005-10. PubMed ID: 27538003
[TBL] [Abstract][Full Text] [Related]
25. Calcium Hydroxylapatite (CaHA) and Aesthetic Outcomes: A Systematic Review of Controlled Clinical Trials.
Amiri M; Meçani R; Llanaj E; Niehot CD; Phillips TL; Goldie K; Kolb J; Muka T; Daughtry H
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541911
[No Abstract] [Full Text] [Related]
26. Hyperdilute Calcium Hydroxylapatite for the Treatment of Perioral Rhytids: A Pilot Study.
Somenek M
Aesthet Surg J Open Forum; 2024; 6():ojae021. PubMed ID: 38660236
[TBL] [Abstract][Full Text] [Related]
27. Prospective Clinical Trial Evaluating the Long-Term Safety and Efficacy of Calcium Hydroxylapatite for Chest Rejuvenation.
Fabi SG; Alhaddad M; Boen M; Goldman M
J Drugs Dermatol; 2021 May; 20(5):534-537. PubMed ID: 33938688
[TBL] [Abstract][Full Text] [Related]
28. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.
Moers-Carpi M; Vogt S; Santos BM; Planas J; Vallve SR; Howell DJ
Dermatol Surg; 2007 Dec; 33 Suppl 2():S144-51. PubMed ID: 18086052
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of injectable CaHA for the treatment of mid-face volume loss.
Beer K; Yohn M; Cohen JL
J Drugs Dermatol; 2008 Apr; 7(4):359-66. PubMed ID: 18459517
[TBL] [Abstract][Full Text] [Related]
30. Hand recontouring with calcium hydroxylapatite (Radiesse).
Edelson KL
J Cosmet Dermatol; 2009 Mar; 8(1):44-51. PubMed ID: 19250166
[TBL] [Abstract][Full Text] [Related]
31. Multilayered injection of calcium hydroxylapatite filler on ischial soft tissue to rejuvenate the previous phase of chronic sitting pressure sore.
Kim J
Clin Cosmet Investig Dermatol; 2019; 12():771-784. PubMed ID: 31686889
[TBL] [Abstract][Full Text] [Related]
32. Diluted Calcium Hydroxylapatite for Skin Tightening of the Upper Arms and Abdomen.
Lapatina NG; Pavlenko T
J Drugs Dermatol; 2017 Sep; 16(9):900-906. PubMed ID: 28915285
[TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Diluted Calcium Hydroxylapatite for the Treatment of Cellulite Dimpling on the Buttocks: Results from an Open-Label, Investigator-Initiated, Single-Center, Prospective Clinical Study.
Durairaj K; Baker O; Yambao M; Linnemann-Heath J; Shirinyan A
Aesthetic Plast Surg; 2024 May; 48(9):1797-1806. PubMed ID: 38253886
[TBL] [Abstract][Full Text] [Related]
34. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
Sadick NS; Katz BE; Roy D
Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
[TBL] [Abstract][Full Text] [Related]
35. Safety and Efficacy of Polymethylmethacrylate-Collagen Gel Filler for Correction of the Pre-jowl Sulcus: A 24-month Prospective Study.
Hevia O
Aesthet Surg J Open Forum; 2022; 4():ojac030. PubMed ID: 35692486
[TBL] [Abstract][Full Text] [Related]
36. Radiesse(®): a novel rejuvenation treatment for the upper arms.
Amselem M
Clin Cosmet Investig Dermatol; 2016; 9():9-14. PubMed ID: 26766918
[TBL] [Abstract][Full Text] [Related]
37. Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study.
Pavicic T
Clin Cosmet Investig Dermatol; 2015; 8():19-25. PubMed ID: 25709485
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Physicochemical Characteristics and Biostimulatory Functions in Two Calcium Hydroxyapatite-Based Dermal Fillers.
Kunzler C; Hartmann C; Nowag B; Shah R; El-Banna R; Backfisch S; Schafer D; Hengl T; Hagedorn N
J Drugs Dermatol; 2023 Sep; 22(9):910-916. PubMed ID: 37683069
[TBL] [Abstract][Full Text] [Related]
39. Longevity and subject-reported satisfaction after minimally invasive jawline contouring.
Müller D; Prinz V; Sulovsky M; Cajkovsky M; Moellhoff N; Cotofana S; Frank K
J Cosmet Dermatol; 2022 Jan; 21(1):199-206. PubMed ID: 34536051
[TBL] [Abstract][Full Text] [Related]
40. Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
Becker CM; Johnson NP; As-Sanie S; Arjona Ferreira JC; Abrao MS; Wilk K; Imm SJ; Mathur V; Perry JS; Wagman RB; Giudice LC
Hum Reprod; 2024 Mar; 39(3):526-537. PubMed ID: 38243752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
